![Specializare nouă în ambulatoriul Spitalului AS Medica. Dr. Ștefania Toma, medic specialist oncologie, oferă consultații începând din această lună - Observatorul Prahovean Specializare nouă în ambulatoriul Spitalului AS Medica. Dr. Ștefania Toma, medic specialist oncologie, oferă consultații începând din această lună - Observatorul Prahovean](https://cdn.observatorulph.ro/wp-content/uploads/2022/02/Dr-Alexandru-Trestioreanu-oncologie-medicala-la-spitalul-AS-Medica-Bucov.jpeg)
Specializare nouă în ambulatoriul Spitalului AS Medica. Dr. Ștefania Toma, medic specialist oncologie, oferă consultații începând din această lună - Observatorul Prahovean
![Brain Tumour Magazine: World Edition 2019/2020 by The International Brain Tumour Alliance (IBTA) - Issuu Brain Tumour Magazine: World Edition 2019/2020 by The International Brain Tumour Alliance (IBTA) - Issuu](https://image.isu.pub/190521104515-505483c220453c468f568518dd64ab14/jpg/page_1.jpg)
Brain Tumour Magazine: World Edition 2019/2020 by The International Brain Tumour Alliance (IBTA) - Issuu
![Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy - Banna - 2022 - Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy - Banna - 2022 -](https://onlinelibrary.wiley.com/cms/asset/bbc0dca3-13ec-4450-a0b5-fbaeb88896a1/tca14256-toc-0001-m.jpg?trick=1701001983152)
Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy - Banna - 2022 -
![Brain Tumour Magazine: World Edition 2021/2022 by The International Brain Tumour Alliance (IBTA) - Issuu Brain Tumour Magazine: World Edition 2021/2022 by The International Brain Tumour Alliance (IBTA) - Issuu](https://image.isu.pub/210831201708-c27ac39aa610d0341fa4d94e02de4fc4/jpg/page_1_thumb_large.jpg)